Skip to Content


In the US, Iodixanol (iodixanol systemic) is a member of the drug class non-ionic iodinated contrast media and is used to treat Aortography, Cerebral Arteriography, Computed Tomography, Coronary Arteriography, Intra-arterial Digital Subtraction Angiography, Peripheral Arteriography, Renal Arteriography, Urography and Venography.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Iodinated x-ray contrast media

Chemical Name

1,3-Benzenedicarboxamide, 5,5'-[(2-hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-

Foreign Names

  • Iodixanolum (Latin)
  • Iodixanol (German)
  • Iodixanol (French)
  • Iodixanol (Spanish)

Generic Names

  • Iodixanol (OS: USAN, BAN, JAN)
  • 2-5410-3A (IS: Nycomed)
  • Iodixanol (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Iodixanolum (PH: Ph. Eur. 8)

Brand Names

  • Visipaque
    Amersham, Latvia; Amersham Health, Spain; Daiichi Sankyo, Japan; GE Healtcare, New Zealand; GE Healthcare, Austria; GE Healthcare, Bosnia & Herzegowina; GE Healthcare, Belgium; GE Healthcare, Bulgaria; GE Healthcare, Switzerland; GE Healthcare, Germany; GE Healthcare, Estonia; GE Healthcare, Finland; GE Healthcare, France; GE Healthcare, Greece; GE Healthcare, Croatia (Hrvatska); GE Healthcare, Hungary; GE Healthcare, Israel; GE Healthcare, Iceland; GE Healthcare, Lithuania; GE Healthcare, Malta; GE Healthcare, Netherlands; GE Healthcare, Poland; GE Healthcare, Romania; GE Healthcare, Serbia; GE Healthcare, Sweden; GE Healthcare, Slovenia; GE Healthcare, Tunisia; General Electric, Chile; HLB Pharma, Argentina; Nycomed, Oman; Opakim, Turkey
  • Visipaque (Iodixanol and Trometamol)
    GE Healthcare, Norway


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.